Orlistat (Or-Xa)
It works as a fat-blocking medicine (blocker).
You may be surprised to learn that the only fat-blocking drug in our diet is orlistat. This is because orlistat is a type of anti-obesity medicine, and it is a type of fat-blocking drug that prevents you from eating fat. Orlistat is an FDA-approved medicine and works by blocking your body from absorbing about the same amount of fat as food.
It is important to note that orlistat is not used in the treatment of obesity, and it may not be used in conjunction with a weight loss diet or other diet modifications.
Orlistat can be used alongside a diet and exercise program that has a good effect on your weight loss. Your doctor may have you have a weight loss program that include some of your usual diet and exercise recommendations, or a program that includes orlistat.
Orlistat is available as a brand-name drug sold under the brand names Alli, Xenical, and OTC. It is available as a capsule and oral tablet, and the oral liquid is a liquid mixture that you can take with or without food.
If you are a patient with an overactive thyroid gland, your doctor may recommend you have orlistat in your diet. This medication may be taken by mouth.
The recommended dosage of orlistat is as follows:
You should only take 1 capsule in 24 hours.
You should not eat more than 6 capsules a day.
You should not take more than 5 capsules a day.
Orlistat is used to treat obesity, which is when excess weight in your weight-bearing areas causes your lower abdominal muscles to tighten. Orlistat blocks fat from being absorbed in the intestines, which reduces your body's ability to absorb fat.
Orlistat is also used to prevent or treat type 2 diabetes, which is when the body has not been properly absorbed by the body.
You should take 1 capsule with a full glass of water, or 1 capsule with a meal.
If you have diabetes, you may be able to reduce your dose by 1 capsule with a meal.
Take 1 capsule with or without food.
Orlistat may be taken with or without food.
Orlistat can cause side effects, such as feeling bloated, feeling unwell, feeling tired or dry mouth, and feeling tired or dry mouth.
Alistat is a popular prescription weight loss medication that contains the active ingredient Orlistat. As a potent prescription weight loss drug, Orlistat works by blocking the absorption of fat in the body, thereby helping individuals lose weight. The market for Orlistat is dominated by a number of generic drugs, which have been steadily increasing in popularity due to their superior efficacy and long-term safety profile. The Orlistat generics market is estimated to reach USD 14.9 billion in 2024, and the market size for Orlistat generics is expected to be USD 21.2 billion by 2030, indicating a significant growth trajectory for the market[1].
The Orlistat market is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.0% to 5.0% by 2028, driven by several key factors:
Generic Competition:The market is influenced by Generic Competition, which is an effective competition mechanism that helps reduce the price competition. Generic Orlistat generics are highly valued by healthcare professionals and consumers, contributing to their improved treatment outcomes[2].
Expansion of Strength and Size:The market is expanding beyond the single branded product, with the growth of multiple generic formulations, such as Orlistat. Companies have launched generics to meet specific healthcare needs and enhance their products, highlighting the growing demand for Orlistat[2].
Despite the growth, the Orlistat market faces several challenges such as high price competition, generic erosion, and generic erosion due to its weight-based formulation. As a result, the Orlistat generics market is projected to remain at a CAGR of 4.0% during the forecast period[1].
The Orlistat market is segmented based on product type and market segmentation:
Generic Drugs:The market is segmented into generics, which includes Orlistat, Contrave, Liraglutide, Saxenda, and Mounjaro. The generics segment is the most dominant, with the market projected to grow to USD 21.2 billion by 2030, driven by its low cost and increasing demand for weight loss treatments[1][3].
Brand Name Brand:Orlistat, Contrave, Liraglutide, Saxenda, and Mounjaro are some of the generic drugs being introduced in the market[3].
The Orlistat generics market is dominated by several key players, such as:
Abonnenti, Amneal Pharmaceuticals, Roche, Sanofi, Teva Pharmaceuticals, Eli Lilly, Novartis, and Sandoz.
Teva, AstraZeneca, Accord, Sanofi, Sandoz, Sandoz Pro, Sandoz Global, Janssenzhen Pharmaceuticals, Takeda, Taband Pharmaceutical Company, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company, Takeda Pharmaceutical Company, Teva Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company, Takeda Pharmaceutical Company, Teva Pharmaceutical Company, Takeda Pharmaceutical Company, Daiichi-Sankyo Co., Ltd., Daiichi Sankyo Co., Ltd., Sun Pharmaceutical Company, Sun Pharmaceutical Company, Daiichi-Sankyo Co., Ltd., Takeda Pharmaceutical Company, Daiichi-Sankyo Co., Ltd., Amneal Pharmaceuticals, Aletza Pharmaceutical, AstraZeneca, Novo Nordisk, Sandoz, Sandoz Co., Ltd., and Takeda Pharmaceutical Company are some of the key players in the Orlistat generics market[1][2][3][4].
Roche, Boehringer Ingelheim, Bristol-Myers Squibb, Novo Nordisk, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, and Sandoz are some of the players that are focusing on expanding their product lines. These companies are working on improving manufacturing safety, improving patient adherence, and creating new patient populations through expanded product launches[1][4].
Orlistat is used to treat obesity and help in weight loss. Orlistat is to be used along with a low-calorie diet and regular physical exercise. Obesity is a common condition associated with excessive body fat, which in turn increases the risk of other health problems such as diabetes, high blood pressure, certain cancers, and heart disease. Intake of more calories than you burn by exercise or daily activities results in obesity.
Orlistat contains Orlistat, which works in the small intestine and stomach and prevents the action of enzymes that break down fat, which is absorbed by the body. Orlistat decreases the absorption of fat from the food you eat. Thus, fat passes through the gut and is excreted in the faeces, which makes the body unable to use fat as a source of energy or convert it into fat tissue. Thereby, Orlistat helps in weight loss.
Take Orlistat as prescribed by your doctor. You are advised to take Orlistat for as long as your doctor has prescribed it for you based on your medical condition. Some people may experience soft stools, sudden bowel motions, flatulence (gas) with or without oily spotting, oily or fatty stools, stomach pain, stool incontinence (involuntary leakage of stools), and runny or liquid stools. Most of these side effects of Orlistat do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
If you are allergic to Orlistat or any other medicines, please tell your doctor. Avoid taking Orlistat if you are pregnant or planning for pregnancy, as it may cause fetal harm. It is not known whether Orlistat is excreted in human milk. Therefore, please consult a doctor if you are a breastfeeding woman. Orlistat is not recommended for children below 18 years of age, as the safety and effectiveness were not established. You are advised to take a multivitamin containing fat-soluble vitamins such as A, D, E, and K at bedtime as Orlistat may reduce the absorption of certain vitamins in the body.
ContraindicationsOrlistat is not recommended for people with a known hypersensitivity to orlistat or to any of the other ingredients in Orlistat. If you have a history of cardiovascular or kidney problems, stomach ulcer, or cardiovascular disease,etermine if Orlistat is your suitable daily medication. Orlistat should not be taken by people who have taken any type of drug for high blood pressure, breast cancer, or seizures. It should also not be taken by people who have lost all their body fat by the time of a new healthy body weight (for example, over-the-counter as used by a doctor).
Tell your doctor if you are history of cardiovascular problems, epilepsy, migraine, or history of seizures. Orlistat may affect your thinking or feelings, making it difficult to control your symptoms. Also, tell your doctor if you or any of your family members have kidney or liver problems. Also, tell your doctor if you have or have ever had seizures. If you have, or have ever had, these symptoms, your family doctor may interfere with or even prevent you from taking Orlistat. Inform your doctor about all your medical history, especially of: kidney problems, liver problems, liver injury, bacterial infections, stomach or intestinal infections, liver problems, heart problems, diabetes, high blood pressure, high cholesterol, high blood pressure, high blood sugar, irregular heartbeat, or heart attack. Orlistat may rarely cause a serious skin reaction such as Stevens-Johnson Syndrome or toxic epidermal necrolysis. Tell your doctor if you have ever had any changes in your vision including any other one of the following: severe skin reactions, such as erythema, peeling, or blistering, a general skin rash, or ulcers. You must contact your doctor if you develop any dark, strong colored patches on your body. You must contact your doctor if you notice any persistent or severe symptoms, including passing stinging or burning in your stinging or burning sensation. Orlistat can cause an upset stomach, having a bad taste in your mouth or a mouth that is full of thick, Statements. Tell your doctor if you are still having any difficulty passing or smelling a strong odour in your stinging and burning sensation. You must contact your doctor if you notice any dark, strong odour in your stinging and burning sensation.
You can buy Orlistat (Xenical/Alli) as an over-the-counter alternative to Wegovy in the UK.
However, Orlistat is a very different type of weight-loss medication, and research suggests it’s not as effective as Wegovy in supporting weight loss.
Wegovy and Orlistat are weight-loss medications approved for use in the UK. However, they are different medications with distinct dosing schedules, costs, and mechanisms of action on the body.
Orlistat is a lipase inhibitor. Lipases are gut enzymes that break down fat from food, enabling the gut to transport fat into the body to be burnt for energy or stored in our fat cells for later use.
Orlistat blocks lipases, preventing some of the dietary fat from our meals from being digested. This leads to fewer calories being absorbed, which can support weight loss.
Orlistat is a prescription medication produced by two pharmaceutical companies in the UK:
Wegovy is a weight-loss jab manufactured by Novo Nordisk. It’s a weekly weight-loss injection with semaglutide as the active ingredient.
Semaglutide is a that helps reduce hunger and appetite, allowing you to eat fewer calories, lose weight, and manage your blood sugar levels.
Wegovy is approved in the UK for individuals living with obesity to help them eat fewer calories and lose weight.
The over-the-counter version of Orlistat will cost around £18 a month, so it’s a very affordable medication.
In comparison, buying Wegovy and the injectable pens required for four weeks from Second Nature will cost £229 a month, rising to £299.
Orlistat is an affordable medication that is generally well-tolerated. However, it’s less effective than Wegovy. Wegovy is twice as effective as Orlistat for weight loss after one year.
So, if you’re looking for the most affordable weight-loss pill you can purchase over the counter, then Orlistat could be an option.
However, if you have a higher budget and are looking for the most effective weight-loss injection in the UK, semaglutide is a better choice.
Semaglutide is designed as an additional tool for weight management and, in most cases, shouldn’t be considered a lifelong medication.
Instead, it should be used to help you kickstart your weight loss and healthy journey while you commit to living a healthier lifestyle.
Ideally, we’d be able to lose weight without medication and lifestyle changes would be enough to support weight loss in the long term.
We’d generally recommend trying Second Nature’s before considering a weight-loss jab.
Changing your habits is the most sustainable way to achieve long-term weight loss, and it’s also less expensive.
At Second Nature, we’ve been trusted by the NHS since 2017 to support people with type 2 diabetes and obesity to lose weight, manage their blood sugar levels, and lead healthier lifestyles for the long term.
In 2022, the NHS in the BMJ that compared the weight loss outcomes of five providers in the National Diabetes Prevention Programme.
Second Nature was more than twice as effective at supporting weight loss than the other four providers.
However, if you’ve decided to try semaglutide (when it’s available) but need support in making positive changes to your lifestyle, Second Nature could be an option for you. But it’s worth noting that we have strict eligibility criteria.
Second Nature has been asked for 100 pills, and 90 are due by the second week of 2022.The 90 pills it recommended 95 are expected to be available in 100 price families.